Skip to Content

Narcan Approval History

  • FDA approved: Yes (First approved November 18th, 2015)
  • Brand name: Narcan
  • Generic name: naloxone
  • Dosage form: Nasal Spray
  • Company: Adapt Pharma, Inc.
  • Treatment for: Opioid Overdose

Narcan Nasal Spray (naloxone) is an intranasal opioid antagonist formulation indicated for the emergency treatment of known or suspected opioid overdose.

Development History and FDA Approval Process for Narcan

Jan 25, 2017Approval Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration
Nov 18, 2015Approval FDA Approves Narcan (naloxone) Nasal Spray to Treat Opioid Overdose
Jul 29, 2015Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Submits NDA to FDA for Narcan (naloxone) Nasal Spray
Jul 23, 2014Lightlake Therapeutics Inc. Files Investigational NDA For Naloxone Nasal Spray For Reversing Opioid Overdose

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.